BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing and full technology transfer.
Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time.
Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.
Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time.
Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.
Location: United Kingdom, Wales, Swansea
Employees: 51-200
Total raised: $2.55M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | BioCity | biocity.co... |
| 17.07.2021 | Archangels | archangels... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.08.2023 | - | $2.55M | - |
Mentions in press and media 5
| Date | Title | Description |
| 01.09.2025 | Guardtech Group set for exciting awards treble to close out buoyant performance in 2025 | The East Anglian cleanroom construction specialists are up for prizes at the Pharma Industry Awards, London Construction Awards and SME National Business Awards grand finals THE GUARDTECH GROUP are set to end a buoyant 2025 with three big a... |
| 23.06.2025 | Monument Therapeutics Reports Positive Phase I Results for Novel Cognitive Impairment in Schizophrenia Treatment | MANCHESTER, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- Monument Therapeutics, a precision neuroscience company, today announced positive topline results from its Phase I clinical trial evaluating MT1988, a novel treatment targeting... |
| 16.08.2023 | BDD Pharma Raises £2M in Funding | BDD Pharma, an Edinburgh, Scotland, UK-based Integrated drug formulation and clinical trials company, raised £2M in funding. The round was led by existing investors including angel syndicate Archangels, Scottish Enterprise, and new investor... |
| 16.08.2023 | Scotland’s BDD secures €2.3M to fuel expansion of drug formulation and clinical trials services | Read this article in: Edinburgh, Scotland-based BDD, an integrated company that specialises in drug formulation and clinical trials, announced on Wednesday that it has raised £2M (approximately €2.3M) in funding. The funding came from exist... |
| - | Bio-Images Drug Delivery | “BDD is a UK based contract research organisation (CRO). We're experts in biopharmaceutics, oral drug formulation, gamma scintigraphy & Phase 1 clinical trials.” |